TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells

Published:2022-12 Issue: Volume:26 Page:101539
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Tan Shuran,Chen Yuanyuan,Du Shi,Li Wenhan,Liu Pan,Zhao Jing,Yang Ping,Cai Jing,Gao Rui,Wang Zehua^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Cervical cancer;Cohen;Lancet,2019

3. Tumor angiogenesis and vascular normalization: alternative therapeutic targets;Viallard;Angiogenesis,2017

4. Tyrosine kinase inhibitors of VEGF receptors: clinical issues and remaining questions;van Cruijsen;Front. Biosci.,2009

5. Modes of resistance to anti-angiogenic therapy;Bergers;Nat. Rev. Cancer,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational identification of small molecules for increased gene expression by synthetic circuits in mammalian cells;2024-09-05

2. TGFβ-ANGPT2-Tie2 axis in cancer-associated fibroblasts reprograms oral cancer cells to embryonic-like cell state with predictive significance of poor prognosis;2024-07-02

3. Notoginsenoside R₁ decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosis;Phytotherapy Research;2024-06-17

4. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions;European Journal of Medicinal Chemistry;2024-06

5. Cervical cancer cell-derived Tie1 expression via PI3K/AKT signaling pathway promotes tumor progression;Experimental Cell Research;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3